🚨 New CME Alert 🚨. Confident in treating NTRK fusion-positive cancer? Our CME covers the latest on RNA-based NGS testing, managing adult & pediatric cases, CNS activity, and sequencing therapies. Want to ensure your patients have access to this cutting-edge care? Head here ➡️

Don’t miss this activity on breast imaging for screening and treatment management. Explore mini chapters on breast density, MRI for active surveillance of DCIS and evaluation of treatment response, and the latest research on AI in breast screening >>>

Stay at the forefront of breast cancer care. We give you expert analysis on the latest breakthroughs and evolving strategies. From managing HER2-positive advanced disease to novel data on emerging therapies, these activities provide critical insights. Earn CME credits while

New activity❗. The treatment paradigm for biliary tract cancers is shifting. Learn about the latest therapeutic advances and how to integrate new targeted treatments into your clinical practice from leading oncology experts ▶️ . #Oncology #CME

The diagnostic journey for NTRK+ thyroid cancer can be tough and frustrating. 💔. But finding this rare biomarker changes everything. Our latest CME activity explores the huge impact of precision care. Learn why testing is key & how new therapies are making a real difference for

Unlock precision medicine for NTRK fusion-positive cancers. Tumor-agnostic TRK inhibitors show remarkable, durable responses in adults & children. Our latest CME activity teaches how to identify patients & integrate these groundbreaking therapies into your clinical practice ➡️

The treatment of biliary tract cancer (BTC) is evolving beyond chemotherapy. Are you current on the latest FDA-approved therapies for HER2-positive disease?. In this new CME, experts provide essential updates ▶️ . #Oncology #CME

World Head and Neck Cancer Day is July 27! Learn how early detection and multidisciplinary care improve outcomes. Explore expert-led CME and NPC resources today. Help spread awareness and support patients.

📆 Save the date! The 18th Annual Hematologic Malignancies Demystified returns in 2026. Join virtual CME/CE sessions led by top experts. 👉 #HMDlive26

🚨 Ready to level up breast cancer care? Join #PBCCLive25 in DC this Sept for only $199 w/ code JULY4TH! From HR+ to TNBC—science, strategy & bold new perspectives await. 👉 @BCJoyceO + @DrReshmaMahtani

If you're making treatment decisions about breast cancer, you have to be in the room at #PBCCLive25. For TNBC, HR+, and HER2+, real-world care meets real-time updates on everything from AE management to QOL strategies. Use Code: JULY4TH!. There's Still Time! 📌

🧠 Master the essentials for detecting ISM:.📌 Key signs & symptoms.📌 Informed referrals.📌 Team-based care strategies.Start learning 👉

Treating CML? 📊 Get up to speed on guideline-driven therapy selection, AE management & survivorship strategies. 🧠 Personalized care starts here →

Could a patient’s feeling of improvement reveal what arm of a clinical trial they’re on?. We dive into why subjective symptoms might be just as telling as tumor scans ➡️ #CME #MedicalEducation #Oncology

Quality of life tells a powerful story!. In this discussion, experts consider how fewer side effects, like joint pain or visual disturbances, may boost patient outcomes. Watch the full livestream now ➡️ #CME #MedicalEducation #Oncology

Have you caught up on the latest updates in antiandrogen therapy for prostate cancer?. Our expert panel broke down the latest 2025 data and what it means for real-world treatment decisions. Don’t miss this essential 30-minute clinical update ▶️

ICYMI!. Did you know patient quality of life might improve with oral SERDs - even before physical tumor progression is seen?. We explore how symptom relief and patient perception impact trial outcomes ➡️ #CME #MedicalEducation #Oncology

ICYMI!. Did you know that sequencing next-gen antiandrogens earlier in prostate cancer care could improve long-term outcomes?. Hear from expert faculty as they explore how evolving strategies are transforming treatment pathways ▶️ #ProstateCancer

🚨 Ready to level up breast cancer care? Join #PBCCLive25 in DC this Sept for only $199 w/ code JULY4TH! From HR+ to TNBC—science, strategy & bold new perspectives await. 👉 @BCJoyceO + @DrReshmaMahtani

🚨 Are you confident managing BRAF-mutated mCRC?. 🧪 Master biomarker testing.🧬 Apply molecular data to guide therapy.🤝 Optimize MDT coordination. 💡 Learn what’s working now → #ESMOGI25